Andere Sprachen EMVision Medical Devices Ltd

Aktien

A2QGQL

AU0000028375

EMV

Markt geschlossen - Australian S.E. Andere Börsenplätze 08:10:40 03.07.2024			% 5 Tage	% 1. Jan.
1,92 ^AUD	-2,29 %		-12,73 %	+13,27 %

29.02.	EMVision Medical Devices sichert sich AU$15.28 Millionen Investition von Keysight Technologies	MT
29.02.	EMVision Medical Devices Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Halbjahr	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

EMVision Medical Devices Sets Up Production Line for Brain Scanner Device; Receives Final Tranche of Grant Funding	24.06.
EMvision Medical Devices Verifies Stroke Detection of Algorithm Technology	27.05.
EMVision Medical Devices Secures AU$15.28 Million Investment from Keysight Technologies	29.02.
EMVision Medical Devices Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	29.02.
EMVision Sets Sight on US With US$10M Keysight Investment	28.02.
EMVision Medical Devices Ltd announced that it expects to receive AUD 15.281174 million in funding from Keysight Technologies, Inc.	28.02.
EMVision Medical Devices Secures Nearly AU$3 Million R&D Tax Rebate for Fiscal Year 2023	18.12.
EMVision Medical Devices Enrolls 150 Patients for Brain Scanner Trials	28.11.
EMVision Medical Devices Assembles 28-Antenna Prototype of Helmet Scanner; Shares Jump 12%	24.10.23
Emvision Reports Positive Interim Results from Stage II Trial of Stroke Detection Algorithm	11.10.23
EMVision Medical Devices Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	30.08.23
Emvision Medical Begins Enrollment at Second Site for Portable Brain Scanner Stage Two Trial	29.06.23
Emvision Medical Devices Limited Receives $1.75 Million Manufacturing Grant Award	13.06.23
Emvision Medical Devices Appoints CEO	31.05.23
EMVision Medical Devices Ltd. Announces Leadership Transition, Effective July 1, 2023	31.05.23
EMVision Medical Devices Ltd. Appoints Forough Khandan as Chief Technology Officer	31.05.23
EVision Medical Devices Begins Stage 2 Clinical Trial for Portable Brain Scanner	29.05.23
EMVision Medical Devices Limited Appoints Professor Alan Coulthard to Clinical Advisory Board	13.03.23
EMVision Medical Devices Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	27.02.23
EMVision Medical Devices Completes Enrollment for Stage 1 Clinical Trial for Brain Scanning Technology	21.02.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen EMVision Medical Devices Ltd

Aktien

A2QGQL

AU0000028375

EMV

Andere Sprachen

Filter